A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcoma

Abstract

The authors developed and internally validated a uterine LMS-specific nomogram to predict 5-year OS. This novel, individualized prognostic model outperforms traditionally used categorical staging systems and may be useful for patient counseling and for better selection of patients for adjuvant therapy trials.